[Current status and prospects of clinical research on portal hypertension in China] [0.03%]
我国门静脉高压临床研究现状及展望
X L Qi
X L Qi
Portal hypertension is an important predictor of the poor prognosis of patients with cirrhosis and hepatocellular carcinoma. The clinical research of portal hypertension should emphasize the cooperation of multidisciplinary team. At present...
H L Yang,G D Gao,C L Liu et al.
H L Yang et al.
In recent years, with the changes in living standards and dietary structure, the incidence of non-alcoholic fatty liver disease has been increasing year by year in China, and the incidence rate in the general population is as high as 29.81%...
[New development for targeted therapy of non-alcoholic fatty liver disease with thyroid hormone receptor beta] [0.03%]
甲状腺激素受体β在非酒精性脂肪肝病靶向治疗中的新进展
B Y Cai,Y Y Hu,Q Feng
B Y Cai
Non-alcoholic fatty liver disease has now become a common hepatic metabolic disease, but there is no universally approved therapeutic drug on the market, so there is an urgent need to explore relevant therapeutic drugs. Several studies have...
Y Wang,Y R Mao
Y Wang
Nucleic acid testing is the gold standard for diagnosing HCV infection, and it is of great significance to guide the treatment of HCV patients and change the follow-up strategy. In recent years, its detection technology has become increasin...
[A case of primary biliary cholangitis stage I combined with portal hypertension] [0.03%]
一例合并门静脉高压的原发性胆汁性胆管炎一期患者
L X Qin,J H Xu,X Y Zhao et al.
L X Qin et al.
[CCAAT/enhancer binding protein δ inhibits invasion and metastasis of liver cancer by regulating M1 type macrophages polarization] [0.03%]
CCAAT/增强子结合蛋白δ通过调节M1型巨噬细胞极化抑制肝癌的侵袭和转移
M Li,Y F Xiong,X J Huang et al.
M Li et al.
Objective: To explore the regulation of macrophage polarization and its effects on liver cancer invasion, metastasis and apoptosis by CCAAT/enhancer binding protein δ (CEBPD). Methods: THP-1 stable transfected cells with knockdown CEBPD (s...
[Analysis of urine metabolic profile in patients with hepatocellular carcinoma] [0.03%]
肝细胞癌患者尿代谢谱的分析
X Chen,L Zhang,Y J Wu et al.
X Chen et al.
Objective: To study the changes of urinary metabolic profile, screen metabolic ions characterization with clinical diagnostic value, and a disease differentiation model establishment, in an attempt to help the clinical diagnosis of hepatoce...
[Value of abnormal expression of Krüppel-like zinc-finger protein transcription factor 5 in the diagnosis and prognosis of liver cancer] [0.03%]
Krüppel样锌指转录因子5异常表达在肝癌的诊断和预后中的价值
W L Sai,L Wang,J Y Sun et al.
W L Sai et al.
Objective: To explore the value of Krüppel-like factor 5 (KLF5), a family member of the zinc finger protein transcription factor, in the diagnosis and prognostic evaluation of hepatocellular carcinoma (HCC). Methods: Cancerous and non-canc...
[Long-term therapeutic effects and liver fibrosis changes with direct-antiviral therapy in HIV/HCV co-infected patients] [0.03%]
人类免疫缺陷病毒/丙型肝炎病毒共感染患者直接抗病毒治疗的长期疗效及肝脏纤维化改变研究
B L Liao,L H Li,H L Zhong et al.
B L Liao et al.
Objective: To investigate the long-term characteristic changes of virus, immune status, and liver fibrosis markers in human immunodeficiency virus (HIV)/hepatitis C virus (HCV) co-infected patients after receiving direct-antiviral agents (D...
[Analysis of risk factors for drug resistant mutations in the reverse transcriptase region in chronic hepatitis B virus-infected patients] [0.03%]
慢性乙型肝炎病毒整合患者发生逆转录酶区耐药突变的风险因素分析
H Zhang,C Y Wang,W K Cao et al.
H Zhang et al.
Objective: To analyze the risk factors that may affect the mutations in the reverse transcriptase region in chronic hepatitis B virus-infected patients. Methods: 678 hospitalized cases with chronic HBV infection who underwent HBV RT testing...